Canine Arthritis Treatment Market
Canine Arthritis Treatment Market Forecasts to 2030 - Global Analysis By Type (Osteoarthritis, Rheumatoid Arthritis and Juvenile Idiopathic Arthritis), By Treatment Type (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Antirheumatic Drugs (DMARDs) and Other Treatment Types), Route of Administration, Distribution Channel and By Geography
Years Covered |
2021-2030 |
Estimated Year Value (2023) |
US $2.3 BN |
Projected Year Value (2030) |
US $3.2 BN |
CAGR (2023-2030) |
5.2% |
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
Largest Market |
North America |
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Canine Arthritis Treatment Market is accounted for $2.3 billion in 2023 and is expected to reach $3.2 billion by 2030 growing at a CAGR of 5.2% during the forecast period. Canine arthritis treatment involves various approaches to managing pain and inflammation in dogs affected by arthritis. These may include medication such as nonsteroidal anti-inflammatory drugs (NSAIDs), supplements like glucosamine and chondroitin, physical therapy, weight management, and lifestyle modifications. In severe cases, surgery may be necessary. The goal is to improve mobility, reduce discomfort, and enhance the quality of life for affected dogs.
According to the American Pet Products Association, an estimated 94.2 million cats and 89.7 million dogs are owned by households in the U.S. during 2017.
Market Dynamics:
Driver:
Rising pet ownership and expenditure on pet healthcare
The increasing trend of pet ownership worldwide has significantly contributed to the growth of the canine arthritis treatment market. As more people embrace pets as integral members of their families, there's a corresponding rise in expenditure on pet healthcare, including treatment for conditions like canine arthritis. Pet owners are increasingly willing to invest in advanced medical care and therapies to ensure the health and well-being of their furry companions, driving demand for innovative treatments and boosting the overall market for canine arthritis treatment.
Restraint:
High cost associated with advanced treatment options
The high cost associated with advanced treatment options, such as stem cell therapy and orthopedic surgeries, presents a significant financial barrier for pet owners seeking comprehensive care for canine arthritis. These advanced treatments often entail substantial expenses, potentially deterring individuals from pursuing them. Consequently, pet owners may resort to less expensive alternatives or even forego treatment altogether due to financial constraints. This affordability challenge underscores the need for accessible and cost-effective solutions to ensure optimal care for pets suffering from arthritis.
Opportunity:
Growing demand for minimally invasive treatment options
Pet owners are increasingly seeking less invasive procedures that offer quicker recovery times and reduce the risk of complications for their furry companions. Minimally invasive techniques, such as arthroscopy and laser therapy, are gaining popularity due to their efficacy and minimal disruption to the pet's lifestyle. This trend presents an opportunity for veterinary clinics and manufacturers to develop and offer innovative, minimally invasive treatments to meet the evolving needs of pet owners and their arthritic pets.
Threat:
Potential side effects and risks associated with certain treatment modalities
Treatments like non-steroidal anti-inflammatory drugs (NSAIDs) or corticosteroids can alleviate symptoms, but they may also lead to adverse reactions such as gastrointestinal issues or renal complications. Such risks may deter pet owners from pursuing these treatments, impacting their willingness to opt for conventional therapies. Consequently, ensuring the safety and efficacy of canine arthritis treatments is essential to mitigating potential threats to market acceptance and pet well-being.
Covid-19 Impact:
The COVID-19 pandemic has influenced the canine arthritis treatment market by altering veterinary care access and pet ownership behaviors. Restrictions on non-essential services and economic uncertainties have led to decreased veterinary visits, affecting diagnosis and treatment. Additionally, financial constraints have influenced pet owners' willingness to invest in advanced treatments, impacting market growth and emphasizing the need for affordable care options.
The nonsteroidal anti-inflammatory drugs (NSAIDs) segment is expected to be the largest during the forecast period
In the canine arthritis treatment market, the nonsteroidal anti-inflammatory drugs (NSAIDs) segment is projected to dominate during the forecast period. This dominance can be attributed to several factors, including their widespread use as a conventional treatment option for managing arthritis-related pain and inflammation in dogs. Additionally, NSAIDs are often preferred by veterinarians due to their efficacy and relatively low cost compared to other advanced treatment modalities, contributing to their anticipated prominence in the market.
The injectables segment is expected to have the highest CAGR during the forecast period
In the canine arthritis treatment market, the injectables segment is projected to experience the highest growth during the forecast period. This growth is attributed to several factors, including the convenience of administration, efficacy in delivering targeted treatment, and the development of innovative injectable therapies. Additionally, advancements in formulation technologies and a shift towards minimally invasive treatment options are driving the demand for injectables, contributing to their anticipated rapid growth trajectory.
Region with largest share:
Over the forecast period, North America is poised to dominate the canine arthritis treatment market. This is due to a large population of pet owners with high disposable income, a well-established veterinary healthcare infrastructure, and advanced research and development activities. Additionally, increasing awareness about pet health and a growing trend towards the humanization of pets further contribute to the region's prominence. Consequently, North America is expected to maintain its leading position in the canine arthritis treatment market in the foreseeable future.
Region with highest CAGR:
Over the forecast period, the Asia Pacific region is poised for rapid growth in the canine arthritis treatment market. This is due to increasing pet ownership rates, rising disposable incomes, and growing awareness of pet healthcare, which are driving demand for arthritis treatments. Additionally, improving veterinary infrastructure and the adoption of advanced treatment modalities are enhancing accessibility to care. As a result, the Asia-Pacific region presents significant opportunities for market expansion, attracting investments, and fostering innovation in canine arthritis treatment solutions.
Key players in the market
Some of the key players in Canine Arthritis Treatment Market include Boehringer Ingelheim Animal Health, Ceva Santé Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health, Hill's Pet Nutrition, InVivo Therapeutics Corporation, Mars Petcare, Merck Animal Health, Norbrook Laboratories, Nutramax Laboratories, Inc., OrthoPets LLC, Rejuvenate Bio, Royal Canin, Veterinary Orthopedic Implants Inc., Vetoquinol S.A., Virbac and Zoetis Inc.
Key Developments:
In February 2024, Rejuvenate Bio partnered with a leading animal health company to develop and commercialize groundbreaking gene therapy for canine osteoarthritis, aiming to address the condition's widespread prevalence and devastating consequences, potentially revolutionizing dog health. This agreement with the global company follows the agreement reached in 2022 with Phibro Animal Health and further validates the gene therapy technology developed by Rejuvenate Bio and their strategy to develop their breakthrough technology in both animal health and human health.
In May 2023, The Food and Drug Administration (FDA) approved Librela, for the control of canine OA pain in the U.S. The first and only injectable monoclonal antibody (mAb) treatment for canine OA is expected to be available in late 2023. A once-monthly injection administered by a veterinary professional, Librela (bedinvetmab injection) works differently than other pain medications, according to a May 5 release from Zoetis.
Types Covered:
• Osteoarthritis
• Rheumatoid Arthritis
• Juvenile Idiopathic Arthritis
Treatment Types Covered:
• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
• Disease-Modifying Antirheumatic Drugs (DMARDs)
• Corticosteroids
• Nutraceuticals
• Physical Therapy and Rehabilitation
• Stem Cell Therapy
• Surgery
• Other Treatment Types
Route of Administrations Covered:
• Oral
• Injectables
• Topical
Distribution Channels Covered:
• Veterinary Clinics and Hospitals
• Retail Pharmacies
• Online Pharmacies
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Canine Arthritis Treatment Market, By Type
5.1 Introduction
5.2 Osteoarthritis
5.3 Rheumatoid Arthritis
5.4 Juvenile Idiopathic Arthritis
6 Global Canine Arthritis Treatment Market, By Treatment Type
6.1 Introduction
6.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
6.3 Disease-Modifying Antirheumatic Drugs (DMARDs)
6.4 Corticosteroids
6.5 Nutraceuticals
6.5.1 Glucosamine
6.5.2 Chondroitin
6.6 Physical Therapy and Rehabilitation
6.7 Stem Cell Therapy
6.8 Surgery
6.9 Other Treatment Types
7 Global Canine Arthritis Treatment Market, By Route of Administration
7.1 Introduction
7.2 Oral
7.3 Injectables
7.4 Topical
8 Global Canine Arthritis Treatment Market, By Distribution Channel
8.1 Introduction
8.2 Veterinary Clinics and Hospitals
8.3 Retail Pharmacies
8.4 Online Pharmacies
9 Global Canine Arthritis Treatment Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Boehringer Ingelheim Animal Health
11.2 Ceva Santé Animale
11.3 Dechra Pharmaceuticals PLC
11.4 Elanco Animal Health
11.5 Hill's Pet Nutrition
11.6 InVivo Therapeutics Corporation
11.7 Mars Petcare
11.8 Merck Animal Health
11.9 Norbrook Laboratories
11.10 Nutramax Laboratories, Inc.
11.11 OrthoPets LLC
11.12 Rejuvenate Bio
11.13 Royal Canin
11.14 Veterinary Orthopedic Implants Inc.
11.15 Vetoquinol S.A.
11.16 Virbac
11.17 Zoetis Inc.
List of Tables
1 Global Canine Arthritis Treatment Market Outlook, By Region (2021-2030) ($MN)
2 Global Canine Arthritis Treatment Market Outlook, By Type (2021-2030) ($MN)
3 Global Canine Arthritis Treatment Market Outlook, By Osteoarthritis (2021-2030) ($MN)
4 Global Canine Arthritis Treatment Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
5 Global Canine Arthritis Treatment Market Outlook, By Juvenile Idiopathic Arthritis (2021-2030) ($MN)
6 Global Canine Arthritis Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
7 Global Canine Arthritis Treatment Market Outlook, By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) (2021-2030) ($MN)
8 Global Canine Arthritis Treatment Market Outlook, By Disease-Modifying Antirheumatic Drugs (DMARDs) (2021-2030) ($MN)
9 Global Canine Arthritis Treatment Market Outlook, By Corticosteroids (2021-2030) ($MN)
10 Global Canine Arthritis Treatment Market Outlook, By Nutraceuticals (2021-2030) ($MN)
11 Global Canine Arthritis Treatment Market Outlook, By Glucosamine (2021-2030) ($MN)
12 Global Canine Arthritis Treatment Market Outlook, By Chondroitin (2021-2030) ($MN)
13 Global Canine Arthritis Treatment Market Outlook, By Physical Therapy and Rehabilitation (2021-2030) ($MN)
14 Global Canine Arthritis Treatment Market Outlook, By Stem Cell Therapy (2021-2030) ($MN)
15 Global Canine Arthritis Treatment Market Outlook, By Surgery (2021-2030) ($MN)
16 Global Canine Arthritis Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
17 Global Canine Arthritis Treatment Market Outlook, By Route of Administration (2021-2030) ($MN)
18 Global Canine Arthritis Treatment Market Outlook, By Oral (2021-2030) ($MN)
19 Global Canine Arthritis Treatment Market Outlook, By Injectables (2021-2030) ($MN)
20 Global Canine Arthritis Treatment Market Outlook, By Topical (2021-2030) ($MN)
21 Global Canine Arthritis Treatment Market Outlook, By Distribution Channel (2021-2030) ($MN)
22 Global Canine Arthritis Treatment Market Outlook, By Veterinary Clinics and Hospitals (2021-2030) ($MN)
23 Global Canine Arthritis Treatment Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
24 Global Canine Arthritis Treatment Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.